We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.14%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$45.6B
AUM Growth
+$1.67B
(+3.8%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
14.15%
Holding
2,318
New
125
Increased
935
Reduced
1,083
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$163M |
| 2 |
American International
AIG
|
+$149M |
| 3 |
Walmart Inc
WMT
|
+$129M |
| 4 |
General Motors
GM
|
+$106M |
| 5 |
Synchrony
SYF
|
+$96.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$144M |
| 2 |
Wells Fargo
WFC
|
+$139M |
| 3 |
AT&T
T
|
+$109M |
| 4 |
Expedia Group
EXPE
|
+$70.5M |
| 5 |
Micron Technology
MU
|
+$67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.45% |
| 2 | Healthcare | 14.87% |
| 3 | Industrials | 12.06% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Financials | 10.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
951
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.38M | 0.01% |
264,224
+35,794
| +16% | +$591K |
|
952
MSCI
MSCI
$41.8B
| $4.37M | 0.01% |
7,896
-713
| -8% | -$377K |
|
953
Doximity
DOCS
$4.74B
| $4.36M | 0.01% |
136,352
+47,288
| +53% | +$1.57M |
|
954
Kelly Services Class A
KELYA
$566M
| $4.34M | 0.01% |
261,834
-40,690
| -13% | -$692K |
|
955
California Resources
CRC
$4.69B
| $4.34M | 0.01% |
112,768
+17,416
| +18% | +$721K |
|
|
INFA
956
DELISTED
Informatica
INFA
| $4.34M | 0.01% |
266,944
+109,162
| +69% | +$1.85M |
|
|
ECHO
957
EchoStar
ECHO
$26.6B
| $4.31M | 0.01% |
238,443
+7,559
| +3% | +$138K |
|
958
Chegg
CHGG
$89.3M
| $4.3M | 0.01% |
265,705
+219,495
| +475% | +$4.11M |
|
959
Enerpac Tool Group
EPAC
$1.89B
| $4.29M | 0.01% |
168,409
+119,990
| +248% | +$3.17M |
|
|
PGTI
960
DELISTED
PGT, Inc.
PGTI
| $4.29M | 0.01% |
170,913
-6,350
| -4% | -$135K |
|
961
Insight Enterprises
NSIT
$4.6B
| $4.29M | 0.01% |
30,002
-1,863
| -6% | -$232K |
|
962
Comfort Systems
FIX
$60.8B
| $4.27M | 0.01% |
29,287
+16,410
| +127% | +$2.13M |
|
|
CCRN
963
DELISTED
Cross Country Healthcare
CCRN
| $4.26M | 0.01% |
191,084
+61,923
| +48% | +$1.62M |
|
|
MDRX
964
DELISTED
Veradigm Inc. Common Stock
MDRX
| $4.26M | 0.01% |
326,723
+145,156
| +80% | +$2.35M |
|
965
Kirby Corp
KEX
$7.26B
| $4.26M | 0.01% |
62,261
-12,060
| -16% | -$831K |
|
|
UNIT
966
Uniti Group
UNIT
$2.38B
| $4.25M | 0.01% |
1,196,104
+215,086
| +22% | +$1.14M |
|
967
Calix
CALX
$2.51B
| $4.24M | 0.01% |
80,732
+42,588
| +112% | +$2.32M |
|
968
MarketAxess Holdings
MKTX
$5.72B
| $4.2M | 0.01% |
10,836
-11,182
| -51% | -$3.96M |
|
969
Victory Capital Holdings
VCTR
$7.27B
| $4.19M | 0.01% |
143,121
+81,527
| +132% | +$2.48M |
|
970
Omega Healthcare
OHI
$13.9B
| $4.19M | 0.01% |
154,336
+56,250
| +57% | +$1.57M |
|
971
Amneal Pharmaceuticals
AMRX
$6.02B
| $4.19M | 0.01% |
3,010,902
+874,650
| +41% | +$1.74M |
|
972
Koppers
KOP
$874M
| $4.18M | 0.01% |
119,466
-2,618
| -2% | -$87K |
|
973
Dr. Reddy's Laboratories
RDY
$10.3B
| $4.16M | 0.01% |
365,505
-169,365
| -32% | -$1.83M |
|
974
Amphastar Pharmaceuticals
AMPH
$858M
| $4.16M | 0.01% |
110,887
-1,716
| -2% | -$56.3K |
|
|
AL
975
DELISTED
Air Lease Corp
AL
| $4.15M | 0.01% |
106,106
+17,348
| +20% | +$726K |
|
Similar funds
AQR Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, AQR Capital Management held 2,318 positions worth $45.6B, up 3.8% from $43.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q1 2023 filing shows 125 new, 935 increased, 1,083 reduced and 165 closed positions. Its largest new stake was GE HealthCare: 300,492 shares worth $24.6M. The largest sale was Meta Platforms (Facebook), an estimated $144M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.
- AQR Capital Management's largest Q1 2023 buy was GE HealthCare: 300,492 shares worth $24.6M.
- AQR Capital Management added most to Cigna in Q1 2023, an estimated $163M increase.
- AQR Capital Management's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $144M.
- AQR Capital Management fully exited Signature Bank in Q1 2023, selling an estimated $18.8M.
- AQR Capital Management's ten largest holdings make up 14% of its $45.6B portfolio in Q1 2023.
- AQR Capital Management opened 125 new positions and closed 165 in Q1 2023.
- AQR Capital Management's portfolio value rose 3.8% quarter-over-quarter to $45.6B.
Based on AQR Capital Management's 13F filing for Q1 2023, filed 15 May 2023.